Dr. Gülay Özgön was one of the invited speakers at the highly interactive and well-attended “Target Cancer 2023” meeting in Cyprus, where the current status of cancer treatment in Turkey was compared with previous years and current global practices, and she was pleased to share her genetic perspective with the participants.

In her speech about BRCA Mutations and HRD, which are considered as the cause of many cancers, she shared with the participants the molecular diagnostic instruments developed in this field.